Patients with rheumatoid arthritis (RA) face heightened risks for COVID-19 infection, hospitalization, and mortality, ...

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...

Further research is needed to determine the risks and benefits of particular sequences of biologic therapies in patients with rheumatoid arthritis who require treatment change owing to inefficacy ...

Treatments for arthritis include medications ... National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS ...

Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...

The Waterloo Road actor appeared on This Morning and revealed he is turning to lifestyle changes to help manage his condition ...

Early treatment escalation to biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) following methotrexate (MTX) failure in new-onset rheumatoid arthritis (RA) does not ...

The second type is rheumatoid arthritis ... board-certified and trained to diagnose and focus on non-surgical treatments of arthritis and related diseases. Dr. Kelsey Pasch of The Baton Rouge ...

An X-ray will show the extent of arthritis. The X-ray may also offer some indication of how successful nonoperative treatments may be in your situation. Most people who have arthritis in the thumb ...

Objectives A reduced adrenal reserve-associated cortisol production relative to the enhanced needs of chronic inflammation (disproportion principle) has been observed in rheumatoid arthritis (RA). We ...

Objective This study examined the safety and efficacy of biological agents, especially tumour necrosis factor (TNF) inhibitors, for HIV-positive rheumatology patients refractory to standard therapy.